Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11982467 | PMC |
| http://dx.doi.org/10.1016/j.gore.2025.101724 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report.
Gynecol Oncol Rep
April 2025
Michigan Medicine, Department of Gynecology Oncology, Ann Arbor, MI, United States.
Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer.
World J Urol
November 2023
Medical Oncology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
Purpose: to assess the respective outcomes of patients with localized muscle-invasive bladder cancer (MIBC) treated by either radical cystectomy (RC) or trimodal treatment (TMT) depending on pathological response to previous neoadjuvant chemotherapy (NAC) assessed on cystectomy specimen or post-NAC transurethral resection (TURB) specimen, respectively.
Patient And Methods: We retrospectively included all consecutive patients treated in one academic center with cisplatin-based NAC followed by RC or TMT for cT2-3N0M0 MIBC between 2014 and 2021. Primary endpoint was metastasis-free survival (MFS) in both treatment groups and according to pathological response to NAC.
Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
Thyroid
November 2021
Department of Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China.
Thermal ablation (TA) has been applied in patients with low-risk papillary thyroid microcarcinoma (PTMC) who refuse surgery or active surveillance (AS). Recently, TA has been proposed as a potential therapeutic option for patients who are suitable for surgery or AS. However, the clinical outcomes of TA versus surgery remains controversial because of a lack of sufficient data.
View Article and Find Full Text PDFBackground: Stereotactic ablative radiotherapy (SABR) is the current standard-of-care in cases of inoperable early stage non-small cell lung cancer (ES-NSCLC). This study aimed to assess the survival outcomes and recurrence patterns after SABR for ES-NSCLC in a hospital setting.
Methods: A single-institution retrospective study was performed which included 109 patients who had undergone SABR.
Combined therapy with bronchial artery embolization and tranexamic acid for hemoptysis.
Acta Radiol
May 2021
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Background: While most previous studies have viewed tranexamic acid as a bridging or temporary therapy, our preliminary study offers insights into the combined therapy of antifibrinolytic agent with endovascular treatment for hemoptysis.
Purpose: To investigate the feasibility and safety of combined therapy, to analyze factors affecting the outcomes of combined therapy, and to compare the effectiveness of combined therapy between groups with different etiologies.
Material And Methods: Between January 2011 and December 2014, 64 patients (33 men, mean age 64.